Analyst Research

Report Title Price
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: S&P Capital IQ Quantitative Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Columbia Laboratories Inc gives Q4, FY 2013 revenue guidance

Thursday, 9 Jan 2014 06:00am EST 

Columbia Laboratories Inc:Sees Q4 2013 total revenues in the range of $7.4 to $8.0 million, as compared with $7.1 million in the Q4 2012.Sees FY 2013, total revenues of $28.8 to $29.4 million. 

Company Quote

0.15 +2.42%
24 Jul 2014